AF
TRIB

Adirondack Funds’s Trinity Biotech TRIB Stock Holding History

Adirondack Funds’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$3.46M Buy
+2,015
New +$4.86M 1.33% 37

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Adirondack Funds's TRIB Position: Q3 2015 in Review

Adirondack Funds opened a new position in Trinity Biotech (TRIB) in Q3 2015: 2,015 shares worth $3.46M. The stake represents 1.33% of the portfolio and ranks #37 among its holdings.

92 funds tracked by Wall St. Rank hold TRIB as of Q3 2015.

  • Adirondack Funds held 2,015 shares of Trinity Biotech worth $3.46M as of Q3 2015.
  • Trinity Biotech was a new Adirondack Funds position in Q3 2015.
  • Trinity Biotech made up 1.33% of Adirondack Funds's portfolio in Q3 2015, its #37 holding.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2015.

Based on Adirondack Funds's 13F filing for Q3 2015, filed 10 Nov 2015.